IntrinsicIntrinsic
← Scroll for more →

Financial Statements — VEON

Balance Sheet

(in billions USD)
MetricQ4 2025Q2 2025Q4 2024Q2 2024Q4 2023Q2 2023Q4 2022Q2 2022Q4 2021Q3 2021Q2 2021
Cash & Equivalents1.731.281.690.861.902.463.112.342.251.501.19
Inventory0.030.020.020.020.020.020.020.120.110.110.12
Total Current Assets----------------3.55--2.50
Goodwill0.400.380.340.350.350.350.391.251.541.412.68
Total Non-current Assets6.105.825.144.945.064.895.3112.0010.5010.0412.25
Total Assets9.228.468.047.338.2213.0115.0817.6915.9215.0214.75
Total Current Liabilities3.432.993.633.073.583.524.646.144.38--4.48
Total Non-current Liabilities4.143.943.133.083.563.885.449.629.648.919.05
Total Liabilities*7.586.976.786.207.1512.0214.3216.1314.4213.7513.53
Total Stockholder Equity1.631.501.261.131.070.990.771.561.511.281.23
← Scroll for more columns →

* Derived from reported values

Income Statement

(in billions USD) (except per-share rows)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q3 2021Q2 2021
Total Revenue1.091.030.922.012.012.07
Selling, General & Admin0.460.450.390.670.630.68
Operating Income0.820.280.240.370.410.37
Pretax Income0.680.140.190.200.240.22
Tax Provision0.070.050.040.080.110.09
Net Income0.610.090.270.180.200.13
Basic EPS0.340.040.140.080.090.06
Diluted EPS0.340.040.140.080.090.06
← Scroll for more columns →

Cash Flow Statement

(in billions USD)
MetricQ2 2021
Operating Cash Flow1.20
Investing Cash Flow(1.13)
Financing Cash Flow(0.55)
← Scroll for more columns →